Nat. Rev. Rheumatol. doi: /nrrheum

Slides:



Advertisements
Similar presentations
ANCA disease: immunoserology and pathogenesis Alenka Vizjak Institute of Pathology · Faculty of Medicine University of Ljubljana, Ljubljana, Slovenia.
Advertisements

ANCA disease: immunoserology and pathogenesis
From: Prevalence of Antineutrophil Cytoplasmic Antibodies in a Large Inception Cohort of Patients with Connective Tissue Disease Ann Intern Med. 1997;126(11):
Microscopic Polyangiitis and Pauci-immune Glomerulonephritis
Vasculitis versus vessel caliber
Recurrence of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Appropriately Immunosuppressed Renal Transplant Patients: A Discussion of Two.
A rare case of concurrent myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO- ANCA)-associated necrotising and crescentic glomerulonephritis and.
Classification scheme for the vasculitides HV, hypersensitivity vasculitis; HSP, Henoch–Schönlein purpura; GPA: granulomatosis with polyangitis; GCA, giant.
Immunofluorescence Indirect Direct proof of antibodies (Ab)
Volume 55, Issue 3, Pages (March 1999)
Figure 3 The induction of anti-DNA antibodies by bacterial DNA
Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.
Figure 2 Representative MSI data obtained from human joints
Lost in the Woods: Granulomatosis with Polyangiitis
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Methods to detect trough levels of therapeutic antibodies
Figure 2 Assays for detecting antidrug antibodies to TNF inhibitors
Figure 3 Proposed mechanisms underlying the links
Volume 60, Issue 5, Pages (November 2001)
Figure 4 Ex vivo synovial tissue culture viability
Figure 1 Worldwide incidence of CCA
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 4 Involvement of SEMA4D in the pathogenesis
Nat. Rev. Nephrol. doi: /nrneph
Volume 79, Issue 6, Pages (March 2011)
Enzyme Immunoassay and Enzyme-Linked Immunosorbent Assay
Figure 1 Metabolic profiling as a tool for studying rheumatic diseases
Figure 2 Expression of complement activation products in renal samples
Nat. Rev. Rheumatol. doi: /nrrheum
Volume 55, Issue 3, Pages (March 1999)
Figure 4 Antinuclear antibodies and disease activity in SLE
Retransplantation in Alport post-transplant anti-GBM disease
Peixoto et al, Supplementary Figure 4.1 A(top)
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 4 Post-test probability as a function of pre-test
Figure 1 IFA testing for identifying the presence of ANAs
Figure 2 Interaction effects between heterozygous HLA‑DRB1
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Statistical approaches for the analysis of metabolomic data
Shunsuke Furuta, David R.W. Jayne  Kidney International 
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
by Yoshiyasu Aoki, Giovanna Tosato, Terry W
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Immunological testing
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Biospecimen handling pipeline
Figure 1 Principles for the diagnosis and management of osteoarthritis
Antineutrophil cytoplasmic antibody-associated vasculitis: Experience from Taichung Veterans General Hospital 施凱翔 梁凱莉 顏廷廷.
Volume 82, Issue 7, Pages (October 2012)
Figure 4 Representative images of skin biopsy sample
Allison J Wildin, DO Medical College of Wisconsin, Milwaukee
Figure 1 The release of DNA from dead and dying cells
(a) Detection of ANETA. NETs were reacted with the ...
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
Fig. 4. Acute lung injury in miR-223−/y mice.
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 Classifications and appearance of CCAs
Kaplan–Meier curves for the time until myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-positive conversion (A: MPO-ANCA, B: proteinase 3.
Volume 53, Issue 5, Pages (May 1998)
Volume 57, Issue 3, Pages (March 2000)
H1. X depletion by RNA interference and colocalization of H1
Detection of Ebola virus infection in nonfatal versus fatal cases.
Volume 126, Issue 2, Pages (February 2004)
Kaplan–Meier curves for the time until development of microscopic polyangiitis (MPA) in patients with idiopathic pulmonary fibrosis according to antineutrophil.
In vivo localization of Iff2, Iff3 (Iff9), Iff5, Iff6, Iff8, and Dcw1 proteins. In vivo localization of Iff2, Iff3 (Iff9), Iff5, Iff6, Iff8, and Dcw1 proteins.
Frequency of PR3-ANCA and MPO-ANCA positivity in ANCA-positive patients with a particular organ system involvement in an inception cohort of 502 ANCA vasculitis.
Nat. Rev. Rheumatol. doi: /nrrheum
Presentation transcript:

Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.140 Figure 1 Historical landmarks of ANCA-testing in small vessel vasculitis Figure 1 | Historical landmarks of ANCA-testing in small vessel vasculitis. In the past 25 years, substantial progress has been made in the development of assays for detecting anti-neutrophil cytoplasmic antibodies (ANCAs). Achievements have been made in antigen characterization (indicated in green), in the standardization of ANCA assays (indicated in blue), in incorporation of ANCAs in nomenclature and classification proposals (indicated in pink) and in ANCA technology (indicated in grey). Consensus statements on ANCA testing are indicated in orange. In this timeline, the dates for the distinct assays formats concern the publications of commercially available immunoassays. CHCC, Chapel Hill Consensus Conference; C-ANCA, cytoplasmic ANCA staining pattern; ELISA, enzyme-linked immunosorbent assay; GPA, granulomatosis with polyangiitis; IIF, indirect immunofluorescence; MPO, myeloperoxidase; PR3, proteinase 3; P-ANCA, perinuclear ANCA staining pattern. Bossuyt, X. et al. (2017) Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.140